Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsInvivoscribe Marketing2024-03-03T11:41:21-08:00March 1st, 2024|Read more
Leveraging Standardized MRD Assays to Guide CLL Treatmentwmm2024-01-25T10:44:11-08:00January 25th, 2024|Read more
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphomawmm2023-04-10T20:22:16-07:00March 23rd, 2023|Read more
Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptorwmm2023-04-10T20:24:04-07:00March 2nd, 2023|Read more
Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Sampleswmm2022-12-29T21:22:21-08:00November 15th, 2022|Read more
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTAInvivoscribe Marketing2023-07-20T17:27:41-07:00July 21st, 2023|Read more
Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer ResearchInvivoscribe Marketing2023-06-05T12:37:16-07:00June 2nd, 2023|Read more
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in JapanInvivoscribe Marketing2023-05-25T17:09:22-07:00May 25th, 2023|Read more
Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation AssayInvivoscribe Marketing2023-05-11T03:12:47-07:00May 11th, 2023|Read more
Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in ChinaInvivoscribe Marketing2023-02-23T06:28:40-08:00February 23rd, 2023|Read more
JSLM Annual Meeting 2024November 28 – December 1, 2024 Osaka, Japan On-site Booth http://jslm71.umin.jp/
AMP 2024November 19 – 23, 2024 Vancouver, BC, Canada On-site Booth & Workshops https://amp24.amp.org/
ICCS 2024October 4-8, 2024 Seattle, WA, US On-site Booth, Corporate Workshop https://www.cytometry.org/2024/